Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Catalent, Inc. Common Stock (NY:CTLT)

63.48 UNCHANGED
Last Price Updated: 7:00 PM EST, Dec 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Catalent, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Catalent, Inc. Reports Preliminary First Quarter Fiscal 2024 Results and Reaffirms Full-Year Fiscal 2024 Guidance
From Catalent, Inc.
Via Business Wire
Preview: Catalent's Earnings
Via Benzinga
Sotera Health Appoints Karen Flynn to Board of Directors
From Sotera Health Services, LLC
Via GlobeNewswire
BioMarin Surges As Activist Investor Elliott Reportedly Builds $1 Billion Stake
The company's recently FDA-approved gene therapy is struggling to gain traction. 
Via Investor's Business Daily
What's Going On With Biotech Contract Service Firm Catalent Stock Today?
Catalent Inc (NYSE: CTLT) shares are trading lower due to its significant exposure to Sarepta Therapeutics Inc (NASDAQ: SRPT) on the back of disappointing data from a pivotal gene therapy trial. 
Via Benzinga
Analyst Ratings for Catalent
Via Benzinga
15 Analysts Have This to Say About Catalent
Via Benzinga
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Catalent, Inc. Announces First Quarter Fiscal Year 2024 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another busy day of trading as we go over the biggest pre-market stock movers worth watching on Tuesday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Weight-Loss Drug Boom Has Another Ripple Effect - Rapid Growth Expected In Fill-Finish Market
Contract drug manufacturers are investing billions of dollars in expanding or constructing facilities that fill the injection pens used for weight-loss drugs like Novo Nordisk A/S's (NYSE: NVO)... 
Via Benzinga
CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Flee to Healthcare Stocks if Recession Rears its Head?
In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends. 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Catalent Appoints David McErlane as Biologics Segment Leader
From Catalent, Inc.
Via Business Wire
Catalent Receives NYSE Notice Regarding Late Form 10-K Filing
From Catalent, Inc.
Via Business Wire
3 Debt-Ridden S&P 500 Stocks to Sell Before It’s Too Late
With debt getting more expensive, it’s become easier to recommend unloading these three S&P 500 stocks now. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Catalent, Inc. to Present at September Investor Conferences
From Catalent, Inc.
Via Business Wire
Barron's Weekend Stock Picks: Globalstar Satellites, Catalent And Dell's Delightful Destiny
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
Via Benzinga
Why Catalent Stock Zoomed 12% Higher This Week
A strong earnings report and a clutch of analyst price target hikes will do that. 
Via The Motley Fool
Catalent's Activist Board Presence To Boost Operational Recovery, Analyst Says
Tuesday, Catalent Inc (NYSE: CTLT) reported Q4 adjusted EPS of $0.09, missing the consensus of $0.10, with sales of $1.07 billion, down 17% Y/Y, slightly above the  
Via Benzinga
RBC Capital Maintains Outperform Rating for Catalent: Here's What You Need To Know
Via Benzinga
Why Catalent Stock Surged Nearly 5% Higher Today
Fourth-quarter performance that wasn't too disappointing, plus a settlement with an activist investor, brought some bulls back to the company's shares. 
Via The Motley Fool
Workhorse Fails to Get Enough Votes to Increase WKHS Stock Count
Workhorse (WKHS) stock is on the move Tuesday after the company failed to get shareholder approval to increase its share count. 
Via InvestorPlace
Can a New CFO Save Canoo (GOEV) Stock?
Canoo (GOEV) stock is getting a boost on Tuesday as investors react to the company naming its new Chief Financial Officer. 
Via InvestorPlace
ORCL Stock Alert: Can AI Hype Really Boost Oracle 20%?
Oracle (ORCL) stock is in the news Tuesday as UBS analyst Karl Keirstead makes a bull case for the information technology company's shares. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
China's Response To Shield Economy From Real Estate Storm, Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle, Google Collaborates With Nvidia In AI Expansion: Today's Top Stories
Bloomberg China Takes Drastic Measures To Shield Economy From Real Estate Storm 
Via Benzinga
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy
Catalent (CTLT) Stock Gains on Elliott Deal
Catalent (CTLT) stock is getting a boost on Tuesday after the company reached an agreement with Elliott Investment Management. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS